Voltage Optimisation technology delivered thousands of pounds of energy savings in Co-operative food stores.
Pharmaceutical companies have been profoundly impacted by rising energy costs, at the same time as costs for raw materials have surged. Energy intensive processes including cleaning and sterilisation, fermentation and complex ventilation systems means that energy costs make up one of the largest overheads for pharmaceutical companies.
Reducing energy costs is a key priority, but it is not the only energy management priority for most pharmaceutical manufacturers. As with all manufacturing sectors, there is growing expectations from legislators, partners and customers that manufacturers show clear, demonstrable progress towards net zero. Alongside the reputational benefits, this is also key to ensuring your organisation meets the expectations of your sector’s Climate Change Agreement.
Powerstar work with customers to improve energy efficiency, a key aspect of reducing overall energy costs, as well as to find ways to use energy more intelligently and cost-effectively across a site. In a sector with narrow margins and growing raw material and supply chain costs, your energy spend is one area that you can have some control over.
Responsible for more global emissions than the automotive industry, better carbon reduction strategies and a clear pathway towards net zero is crucial for pharmaceutical manufacturers. Powerstar have helped dozens of manufacturers slash their emissions through a variety of different means, from energy efficiency technologies such as voltage optimisation and low-loss transformers to maximising the performance of on-site renewable generation by incorporating it into a smart microgrid.
The high-volume nature of most pharmaceuticals manufacturing, and the sensitivity of many production processes, means that they can be particularly susceptible to power disruption. Powerstar specialise in delivering site-wide power resilience using battery energy storage that, when not being called upon to protect the site from a disruption event, actively contributes to wider energy management goals, including cost and carbon reduction.
Solving Complex Problems
The complex manufacturing processes and HVAC systems required for the pharmaceuticals industry can make changes to energy infrastructure a complex process. Powerstar’s smart microgrid projects have the potential to unlock many projects that would otherwise be prohibitively complex, or that would exceed a site’s available capacity. Our intelligent energy management system can ensure that an entire site sources, generates and uses electricity as efficiently as possible.
Read our free manufacturing white paper on
“Industry 4.0 plus Net Zero”
Related case studies
Eliminating energy waste to achieve their net zero ambition. Wernick achieved savings of 9.2% in Energy Costs & 19 tonnes CO2 per annum
All defense sites have critical power requirements and most will ensure that they are able to run independently from the grid by having their own power generation
Parkinson Spencer Refractories achieved protection from Power Disruptions, a 5% reduction in Energy Costs and extra revenue through GridBeyond with a BESS
You might also be interested in
As other costs increase for pharmaceutical manufacturers, energy is one area of costs they are able to mitigate with the right strategy
The rise of renewable energy presents new potential power disruptions for manufacturers
Following a lengthy period of disruption caused by the COVID-19 pandemic and ongoing uncertainty following the UK’s departure from the EU, many British businesses are focusing on a sustained period of effective recovery.
From high value and high volume manufacturing to data centres and healthcare, an uninterruptible power supply (UPS) is critical for many companies and organisations and this need will only grow as we move forward with Industry 4.0, smarter cities and a net zero world.